JP2021522854A5 - - Google Patents
Info
- Publication number
- JP2021522854A5 JP2021522854A5 JP2021510271A JP2021510271A JP2021522854A5 JP 2021522854 A5 JP2021522854 A5 JP 2021522854A5 JP 2021510271 A JP2021510271 A JP 2021510271A JP 2021510271 A JP2021510271 A JP 2021510271A JP 2021522854 A5 JP2021522854 A5 JP 2021522854A5
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- antigen
- promoter
- heterologous antigen
- heterologous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024195785A JP2025032104A (ja) | 2018-05-01 | 2024-11-08 | ＨＳＶ－２－ＤＥＬＴＡ－ｇＤ ワクチンおよびそれらの生産および使用のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862665050P | 2018-05-01 | 2018-05-01 | |
| US62/665,050 | 2018-05-01 | ||
| PCT/US2019/030259 WO2019213305A1 (en) | 2018-05-01 | 2019-05-01 | HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195785A Division JP2025032104A (ja) | 2018-05-01 | 2024-11-08 | ＨＳＶ－２－ＤＥＬＴＡ－ｇＤ ワクチンおよびそれらの生産および使用のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522854A JP2021522854A (ja) | 2021-09-02 |
| JP2021522854A5 true JP2021522854A5 (https=) | 2022-05-09 |
| JP7671982B2 JP7671982B2 (ja) | 2025-05-07 |
Family
ID=68386663
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510271A Active JP7671982B2 (ja) | 2018-05-01 | 2019-05-01 | ＨＳＶ－２－ＤＥＬＴＡ－ｇＤ ワクチンおよびそれらの生産および使用のための方法 |
| JP2024195785A Pending JP2025032104A (ja) | 2018-05-01 | 2024-11-08 | ＨＳＶ－２－ＤＥＬＴＡ－ｇＤ ワクチンおよびそれらの生産および使用のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195785A Pending JP2025032104A (ja) | 2018-05-01 | 2024-11-08 | ＨＳＶ－２－ＤＥＬＴＡ－ｇＤ ワクチンおよびそれらの生産および使用のための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210236625A1 (https=) |
| EP (1) | EP3787680A4 (https=) |
| JP (2) | JP7671982B2 (https=) |
| CN (1) | CN112368017A (https=) |
| AU (1) | AU2019262056B2 (https=) |
| CA (1) | CA3098572A1 (https=) |
| IL (1) | IL278294B2 (https=) |
| WO (1) | WO2019213305A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113430178B (zh) * | 2021-06-21 | 2022-10-11 | 武汉大学 | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 |
| WO2024145863A1 (en) * | 2023-01-05 | 2024-07-11 | Virogin Biotech (Shanghai) Ltd. | A NOVEL mRNA VACCINE FOR THE TREATMENT AND PREVENTION OF HPV-ASSOCIATED LESIONS AND TUMORS |
| CN116497049B (zh) * | 2023-05-04 | 2024-03-22 | 江苏三仪生物工程有限公司 | 一种表达犬疱疹病毒gD糖基化蛋白的重组菌及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2375113B (en) * | 2000-01-21 | 2004-10-20 | Biovex Ltd | A modified, oncolytic, non-laboratory HSV strain and its use in treating cancer |
| GB0326798D0 (en) * | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
| US20070003520A1 (en) | 2003-11-17 | 2007-01-04 | Brown Susanne M | Mutant viruses |
| CA2587084C (en) * | 2004-10-08 | 2019-07-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Modulation of replicative fitness by using less frequently used synonym ous codons |
| WO2008027394A2 (en) * | 2006-08-28 | 2008-03-06 | The Wistar Institute Of Anatomy And Biology | Constructs for enhancing immune responses |
| TR201802741T4 (tr) * | 2010-05-14 | 2018-03-21 | Univ Oregon Health & Science | Rekombinant hcmv ve rhcmv vektörleri ve bunların kullanımları. |
| EP3943106A1 (en) | 2014-03-03 | 2022-01-26 | Albert Einstein College of Medicine | Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors |
-
2019
- 2019-05-01 IL IL278294A patent/IL278294B2/en unknown
- 2019-05-01 CA CA3098572A patent/CA3098572A1/en active Pending
- 2019-05-01 AU AU2019262056A patent/AU2019262056B2/en active Active
- 2019-05-01 CN CN201980044626.3A patent/CN112368017A/zh active Pending
- 2019-05-01 WO PCT/US2019/030259 patent/WO2019213305A1/en not_active Ceased
- 2019-05-01 JP JP2021510271A patent/JP7671982B2/ja active Active
- 2019-05-01 US US17/051,992 patent/US20210236625A1/en not_active Abandoned
- 2019-05-01 EP EP19796848.0A patent/EP3787680A4/en active Pending
-
2022
- 2022-11-29 US US18/071,109 patent/US12150986B2/en active Active
-
2024
- 2024-11-08 JP JP2024195785A patent/JP2025032104A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rendon-Marin et al. | Tropism and molecular pathogenesis of canine distemper virus | |
| Robison et al. | The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly | |
| TWI605124B (zh) | 新穎桿狀病毒載體及使用方法 | |
| JP2021061848A5 (https=) | ||
| Welch et al. | Inhibition of Nipah virus by defective interfering particles | |
| Latham et al. | Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins | |
| Havenga et al. | Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER. C6 cells | |
| JP2021522854A5 (https=) | ||
| JP2017503482A5 (https=) | ||
| Arella et al. | Molecular cloning and characterization of cytoplasmic polyhedrosis virus polyhedrin and a viable deletion mutant gene | |
| Perez et al. | N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry | |
| JP2019516410A5 (https=) | ||
| DK1012244T3 (da) | Rhabdovira med genteknologisk manipulerede kapper | |
| FI3247388T3 (fi) | Rekombinantti ihmisen/naudan parainfluenssavirus 3 (b/hpiv3), joka ilmentää kimeeristä rsv:n/bpiv3:n f-proteiinia, ja sen käyttötapoja | |
| RU2012108128A (ru) | Новый вирусный вектор | |
| JP2017510262A5 (https=) | ||
| Yu et al. | A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice | |
| CN117384965A (zh) | 牛结节性皮肤病病毒tk基因缺失毒株lsdv-△tk的构建方法 | |
| JP2024544566A5 (https=) | ||
| Chen et al. | The improvement and application of lentivirus-mediated gene transfer and expression system in penaeid shrimp cells | |
| Lawrence et al. | Comparison of heterologous prime-boost strategies against human immunodeficiency virus type 1 Gag using negative stranded RNA viruses | |
| IL278294B1 (en) | HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE | |
| Paneth Iheozor-Ejiofor et al. | Vaccinia virus-free rescue of fluorescent replication-defective vesicular stomatitis virus and pseudotyping with Puumala virus glycoproteins for use in neutralization tests | |
| Bruce et al. | Complete genome sequence of pig-tailed macaque rhadinovirus 2 and its evolutionary relationship with rhesus macaque rhadinovirus and human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus | |
| Perez et al. | Identification of the Borna disease virus (BDV) proteins required for the formation of BDV-like particles |